Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing
Reexamination Certificate
2011-08-02
2011-08-02
Schultz, Doug (Department: 1633)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
C435S006120, C514S04400A
Reexamination Certificate
active
07988957
ABSTRACT:
A gene transfer efficiency enhancer of the present invention which contains a histone deacetylase inhibitor (especially compound (A)) as an active ingredient is capable of enhancing gene transfer efficiency in a gene transfer mediated by an adeno-associated virus vector while retaining the advantages of the adeno-associated virus vector.
REFERENCES:
patent: 6410300 (2002-06-01), Samulski et al.
patent: WO 974707 (1997-12-01), None
M. Jung. Current Med. Chem. (2001) 8, 150-1511.
M.E. Goldsmith et al. Clin. Cancer Res. (2003) 9, pp. 5394-5401.
H. J. Kwon et al. Int. J. Cancer (2002) 97, pp. 290-296.
G. Rajgolikar et al. Recent Cancer Res. Treat. (1998) 51, pp. 20-38.
M. Murata et al. Jpn. J. Cancer Res. (2000) 91, pp. 1154-1160.
R. Furumai et al. Cancer Res. (2002) 62, pp. 4916-3921.
R.R. Frey et al. Bioorg. Med. Chem. Let. (2002) 12, pp. 3443-3447.
Nakajima et al. Experimental Cell Research 241, 126-133 (1998).
Alisky et al. Human Gene Therapy 11:2315-2329 (Nov. 20, 2000).
Takashi Okada et al.; “A Histone Deacetylase Inhibitor Enhances Recombinant Adeno-associated Virus-Mediated Gene Expression in Tumor Cells”; Nov. 2005; pp. 1-9; Division of Genetic Therapeutics, Center for Molecular Medicine, Tochigi, Japan.
Wen Yong Chen et al., “Reactivation of Silenced, Virally Transduced Genes by Inhibitors of Histone Deacetylase”; Proc. Natl. Acad. Scie. USA, vol. 94, pp. 5798-5803, 1997.
Masaki Kitazono et al.; “Enhanced Adenovirus Transgene Expression in Malignant Cells Treated with the Histone Deacetylase Inhibitor”; FR901228; Cancer Research; vol. 61, pp. 6328-6330; 2001.
L. David Dion; “Amplification of Recombinant Adenoviral Transgene Products Occurs by Inhibition of Histone Deacetylase”; Virology; vol. 231, pp. 201-209; 1997.
Kenneth Lundstron; “Latest Development in Viral Vectors for Gene Therapy”; Trends in Biotechnology; vol. 21, No. 3; Mar. 2003.
Genevieve Almousni et al.; “Histone Acetylation Influences Both Gene Expression and Development ofXenopus laevis”; Developmental Biology; vol. 165, pp. 654-669; 1994.
Okada Takashi
Ozawa Keiya
Bacon & Thomas PLLC
Genesis Healthcare Corp.
Schultz Doug
LandOfFree
Gene introduction efficiency enhancer does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gene introduction efficiency enhancer, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene introduction efficiency enhancer will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2762152